ID   Ad-AH
AC   CVCL_X200
SY   AdAH
DR   Wikidata; Q54608585
RX   PubMed=6088881;
RX   PubMed=6318711;
RX   PubMed=6324641;
RX   PubMed=24991015;
CC   Virology: EBV-negative.
CC   Doubling time: 26 hours (Note=At 59th passage) (PubMed=6088881).
CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IY39 ! 2-27-Ad
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 05-10-23; Version: 12
//
RX   PubMed=6088881; DOI=10.1093/jnci/73.3.711;
RA   Takimoto T., Ogura H., Ohno S., Umeda R., Hatano M.;
RT   "Tumorigenicity of nasopharyngeal carcinoma hybrid cell line.";
RL   J. Natl. Cancer Inst. 73:711-715(1984).
//
RX   PubMed=6318711; DOI=10.1007/BF00454266;
RA   Takimoto T., Kamide M., Umeda R.;
RT   "Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen
RT   (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT).";
RL   Arch. Otorhinolaryngol. 239:87-92(1984).
//
RX   PubMed=6324641; DOI=10.1177/000348948409300213;
RA   Takimoto T., Furukawa M., Hatano M., Umeda R.;
RT   "Epstein-Barr virus nuclear antigen-positive nasopharyngeal hybrid
RT   cells.";
RL   Ann. Otol. Rhinol. Laryngol. 93:166-169(1984).
//
RX   PubMed=24991015; DOI=10.1128/JVI.01457-14;
RA   Strong M.J., Baddoo M., Nanbo A., Xu M., Puetter A., Lin Z.;
RT   "Comprehensive RNA-seq analysis reveals contamination of multiple
RT   nasopharyngeal carcinoma cell lines with HeLa cell genomes.";
RL   J. Virol. 88:10696-10704(2014).
//